PRME logo

Prime Medicine (PRME) Cash From Investing

Annual CFI

$68.46 M
+$49.75 M+265.86%

December 31, 2024


Summary


Performance

PRME Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRMEcash flowmetrics:

Quarterly CFI

$48.25 M
-$2.09 M-4.15%

December 31, 2024


Summary


Performance

PRME Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRMEcash flowmetrics:

TTM CFI

$68.46 M
+$6.97 M+11.33%

December 31, 2024


Summary


Performance

PRME TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRMEcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PRME Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+265.9%+230.3%+1509.6%
3 y3 years+193.0%+230.3%+1509.6%
5 y5 years+6546.1%+230.3%+1509.6%

PRME Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+193.0%-4.2%+195.0%at high+422.1%
5 y5-yearat high+193.0%-4.2%+195.0%at high+422.1%
alltimeall timeat high+193.0%-4.2%+195.0%at high+422.1%

Prime Medicine Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$68.46 M(+265.9%)
$48.25 M(-4.1%)
$68.46 M(+11.3%)
Sep 2024
-
$50.34 M(+630.2%)
$61.49 M(+451.6%)
Jun 2024
-
$6.89 M(-118.6%)
$11.15 M(+162.1%)
Mar 2024
-
-$37.03 M(-189.7%)
$4.25 M(-89.7%)
Dec 2023
$18.71 M(-139.7%)
$41.28 M(-405.6%)
$41.28 M(-294.2%)
Dec 2022
-$47.10 M
-
-
DateAnnualQuarterlyTTM
Sep 2022
-
-$13.51 M(-73.4%)
-$21.25 M(+174.5%)
Jun 2022
-
-$50.79 M(-264.4%)
-$7.74 M(-118.0%)
Mar 2022
-
$30.89 M(+154.2%)
$43.05 M(+254.2%)
Dec 2021
-$73.63 M(+6832.8%)
$12.15 M(>+9900.0%)
$12.15 M(>+9900.0%)
Dec 2020
-$1.06 M
-
-
Dec 2019
-
$0.00
$0.00

FAQ

  • What is Prime Medicine annual cash flow from investing activities?
  • What is the all time high annual CFI for Prime Medicine?
  • What is Prime Medicine annual CFI year-on-year change?
  • What is Prime Medicine quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Prime Medicine?
  • What is Prime Medicine quarterly CFI year-on-year change?
  • What is Prime Medicine TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Prime Medicine?
  • What is Prime Medicine TTM CFI year-on-year change?

What is Prime Medicine annual cash flow from investing activities?

The current annual CFI of PRME is $68.46 M

What is the all time high annual CFI for Prime Medicine?

Prime Medicine all-time high annual cash flow from investing activities is $68.46 M

What is Prime Medicine annual CFI year-on-year change?

Over the past year, PRME annual cash flow from investing activities has changed by +$49.75 M (+265.86%)

What is Prime Medicine quarterly cash flow from investing activities?

The current quarterly CFI of PRME is $48.25 M

What is the all time high quarterly CFI for Prime Medicine?

Prime Medicine all-time high quarterly cash flow from investing activities is $50.34 M

What is Prime Medicine quarterly CFI year-on-year change?

Over the past year, PRME quarterly cash flow from investing activities has changed by +$85.28 M (+230.30%)

What is Prime Medicine TTM cash flow from investing activities?

The current TTM CFI of PRME is $68.46 M

What is the all time high TTM CFI for Prime Medicine?

Prime Medicine all-time high TTM cash flow from investing activities is $68.46 M

What is Prime Medicine TTM CFI year-on-year change?

Over the past year, PRME TTM cash flow from investing activities has changed by +$64.20 M (+1509.62%)